Davis Capital Management’s TG Therapeutics TGTX Stock Holding History

Davis Capital Management’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$440	Buy	+8	New	+$327	﹤0.01%	637

Other funds holding TGTX

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

TAM

Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

Davis Capital Management's TGTX Position: Q2 2026 in Review

Davis Capital Management opened a new position in TG Therapeutics (TGTX) in Q2 2026: 8 shares worth $440. The stake represents ﹤0.01% of the portfolio and ranks #637 among its holdings.

88 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Davis Capital Management held 8 shares of TG Therapeutics worth $440 as of Q2 2026.
TG Therapeutics was a new Davis Capital Management position in Q2 2026.
TG Therapeutics made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #637 holding.
88 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.